Koninklijke DSM (NASDAQ:RDSMY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “

Separately, HSBC Holdings plc initiated coverage on shares of Koninklijke DSM in a research note on Friday, September 1st. They issued a “buy” rating on the stock.

Koninklijke DSM (NASDAQ:RDSMY) opened at 20.898 on Wednesday. The firm has a 50 day moving average price of $19.81 and a 200 day moving average price of $18.62. Koninklijke DSM has a 12-month low of $14.50 and a 12-month high of $20.94. The company has a market cap of $14.62 billion and a PE ratio of 17.250.

ILLEGAL ACTIVITY WARNING: “Koninklijke DSM (RDSMY) Lifted to “Hold” at Zacks Investment Research” was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/10/11/koninklijke-dsm-rdsmy-lifted-to-hold-at-zacks-investment-research.html.

Koninklijke DSM Company Profile

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company’s segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.

Get a free copy of the Zacks research report on Koninklijke DSM (RDSMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.